Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Scentre sells half of Westfield Mt Gravatt for A$882.5m, keeps control
Scentre Group is selling half of Westfield Mt Gravatt to Australian Retirement Trust for A$882.5 million. The deal values the mall at a 3.5%
YMTC parent CCSH files for $4.6 billion Shanghai IPO
CCSH Corp., parent of memory chip maker YMTC, has filed for a Shanghai IPO seeking up to 33 billion yuan. The funds will boost NAND flash pr
Visa Flags Hims & Hers Over Weight-Loss Subscription Chargebacks
Visa flagged Hims & Hers Health's weight-loss subscriptions after a July spike in card disputes, putting the telehealth firm in a monitoring
CoVolt Power files for NYSE IPO to ride AI data center electricity boom
CoVolt Power has filed for a US IPO, aiming to capitalize on the AI data center construction boom. The engineering firm builds energy infras
NHTSA escalates review of GM's L87 engine recall fix
NHTSA is digging deeper into GM's fix for its L87 V8 engine, covering nearly 1 million vehicles. Thousands of owners reported failures even
Encore Boston Harbor faces strike threat as 1,350 workers authorize walkout
Unite Here Local 26 and Teamsters Local 25 voted to authorize a strike at Encore Boston Harbor, covering about 1,350 workers. The walkout co
Samsung unveils record $80B shareholder return plan to win back investors
Samsung Electronics announced a record shareholder return program of up to $80 billion for this year, aiming to boost its struggling share p
Metzler lifts GEA price target to €74 but sees limited upside ahead
Metzler Capital Markets raised its price target on GEA to €74 and lifted 2026 sales, EBIT, and EPS estimates. The bank cautions that the sto
Array Technologies' new products now half of order book, RBC says
RBC Capital Markets says customer-built solar tracker products now account for about half of Array Technologies' order book. The company lau
Gossamer Bio's $250M raise tied to FDA acceptance of seralutinib filing
Gossamer Bio has secured a private placement worth up to $250 million, but most of the cash will only arrive if the FDA agrees to review its
Geberit gets forecast lift but valuation still looks tight
Geberit's strong quarter prompted AlphaValue/Baader to lift its 2026-2028 sales and EBITDA estimates by about 4%. But the research firm stil
NHTSA reopens GM's L87 engine recall after post-fix failures
NHTSA has opened a new engineering analysis covering nearly 1 million GM vehicles with L87 V8 engines after hundreds of post-repair failure